These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27477967)

  • 1. The risks behind Dengvaxia recommendation.
    Aguiar M; Stollenwerk N; Halstead SB
    Lancet Infect Dis; 2016 Aug; 16(8):882-3. PubMed ID: 27477967
    [No Abstract]   [Full Text] [Related]  

  • 2. The value of multi-country joint regulatory reviews: The experience of a WHO joint technical consultation on the CYD-TDV (Dengvaxia®) dossier.
    Vannice K; Chocarro L; Pfleiderer M; Bellah A; Ward M; Yoon IK; Hombach J
    Vaccine; 2017 Oct; 35(43):5731-5733. PubMed ID: 28755835
    [No Abstract]   [Full Text] [Related]  

  • 3. The Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits.
    Deen J
    PLoS Med; 2016 Nov; 13(11):e1002182. PubMed ID: 27898675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing dengue vaccine: Implications for diagnosis in dengue vaccinated subjects.
    Alagarasu K
    Vaccine; 2016 May; 34(25):2759-61. PubMed ID: 27142330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue vaccine--time to act now.
    Pang T; Thiam DGY; Tantawichien T; Ismail Z; Yoksan S
    Lancet; 2015 May; 385(9979):1725-1726. PubMed ID: 25943934
    [No Abstract]   [Full Text] [Related]  

  • 6. SAGE committee advice on dengue vaccine.
    Pang T
    Lancet Infect Dis; 2016 Aug; 16(8):880-2. PubMed ID: 27477966
    [No Abstract]   [Full Text] [Related]  

  • 7. Dengue vaccine development: a 75% solution?
    Halstead SB
    Lancet; 2012 Nov; 380(9853):1535-6. PubMed ID: 22975339
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of tetravalent dengue vaccine in Thai schoolchildren.
    McKibben L
    Lancet; 2013 Mar; 381(9872):1094. PubMed ID: 23540848
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of tetravalent dengue vaccine in Thai schoolchildren.
    Moi ML; Takasaki T; Kurane I
    Lancet; 2013 Mar; 381(9872):1094. PubMed ID: 23540846
    [No Abstract]   [Full Text] [Related]  

  • 10. Dengue vaccine efficacy trial: does interference cause failure?
    Swaminathan S; Khanna N; Herring B; Mahalingam S
    Lancet Infect Dis; 2013 Mar; 13(3):191-2. PubMed ID: 23427882
    [No Abstract]   [Full Text] [Related]  

  • 11. Status of vaccine research and development of vaccines for dengue.
    Vannice KS; Durbin A; Hombach J
    Vaccine; 2016 Jun; 34(26):2934-2938. PubMed ID: 26973072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first licensed dengue vaccine: an important tool for integrated preventive strategies against dengue virus infection.
    Pitisuttithum P; Bouckenooghe A
    Expert Rev Vaccines; 2016 Jul; 15(7):795-8. PubMed ID: 27171845
    [No Abstract]   [Full Text] [Related]  

  • 13. An effective dengue vaccine: a glass half full or half empty?
    Arya V
    Natl Med J India; 2013; 26(1):38-9. PubMed ID: 24066994
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of tetravalent dengue vaccine in Thai schoolchildren - Authors' reply.
    Sabchareon A; Wallace D; Lang J; Bouckenooghe A; Moureau A
    Lancet; 2013 Mar; 381(9872):1094-5. PubMed ID: 23540847
    [No Abstract]   [Full Text] [Related]  

  • 15. Dengue vaccines for travelers: has the time come?
    Wilder-Smith A
    J Travel Med; 2015; 22(3):200-2. PubMed ID: 25827475
    [No Abstract]   [Full Text] [Related]  

  • 16. Consider stopping dengvaxia administration without immunological screening.
    Aguiar M; Halstead SB; Stollenwerk N
    Expert Rev Vaccines; 2017 Apr; 16(4):301-302. PubMed ID: 28010152
    [No Abstract]   [Full Text] [Related]  

  • 17. Introduction to risk management plans in the Singapore context.
    Ho CSC; Tan LLB; Chan CL
    Singapore Med J; 2019 Sep; 60(9):483-486. PubMed ID: 31570951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sanofi's dengue vaccine first to complete phase 3.
    Sinha G
    Nat Biotechnol; 2014 Jul; 32(7):605-6. PubMed ID: 25004214
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dengue vaccines. A reality for Argentina?].
    Orellano PW; Salomón OD
    Medicina (B Aires); 2016; 76(2):98-102. PubMed ID: 27028058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue vaccine acceptance and willingness to pay.
    Harapan H; Fajar JK; Sasmono RT; Kuch U
    Hum Vaccin Immunother; 2017 Apr; 13(4):786-790. PubMed ID: 27905832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.